25/08/2021 (Agence Europe) – On Tuesday 24 August, the European Medicines Agency (EMA) gave its approval to increase the production capacity of the Covid-19 vaccine developed by Pfizer/BioNTech (Comirnaty): the agency approved a new manufacturing line at the German production site in Marburg as well as a new manufacturing site for the finished product, which will be located in France, in Saint-Rémy-sur-Avre. These changes are expected to increase the manufacturing capacity of the active...